| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |